Cargando…
A Carrier-Free Folate Receptor-Targeted Ursolic Acid/Methotrexate Nanodelivery System for Synergetic Anticancer Therapy
PURPOSE: To avoid undefined metabolic mechanisms and to eliminate potential side effects of traditional nanocarriers, new green carriers are urgently needed in cancer treatment. Carrier-free nanoparticles (NPs) based on ursolic acid (UA) have attracted significant attention, but the UA NPs targeting...
Autores principales: | Lan, Jin-Shuai, Qin, Yan-Hong, Liu, Li, Zeng, Rui-Feng, Yang, Yang, Wang, Kai, Ding, Yue, Zhang, Tong, Ho, Rodney J Y |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938229/ https://www.ncbi.nlm.nih.gov/pubmed/33692622 http://dx.doi.org/10.2147/IJN.S287806 |
Ejemplares similares
-
Advances in Nanodelivery of Green Tea Catechins to Enhance the Anticancer Activity
por: Jiang, Yike, et al.
Publicado: (2021) -
Hydroxyethylcellulose as a methotrexate carrier in anticancer therapy
por: Ciekot, Jarosław, et al.
Publicado: (2020) -
Hydroxyethyl starch as an effective methotrexate carrier in anticancer therapy
por: Goszczyński, T M, et al.
Publicado: (2014) -
Nanodelivery and anticancer effect of a limonoid, nimbolide, in breast and pancreatic cancer cells
por: Patra, Arjun, et al.
Publicado: (2019) -
Utility
of Intravenous Curcumin Nanodelivery Systems
for Improving In Vivo Pharmacokinetics and Anticancer
Pharmacodynamics
por: Bagheri, Mahsa, et al.
Publicado: (2022)